Patient population
| Characteristic | N=182 |
| Age at diagnosis | |
| <50 years | 68 (37%) |
| ≥50 years | 114 (63%) |
| Race | |
| White | 131 (72%) |
| Non-white | 34 (19%) |
| Unknown | 17 (9.3%) |
| Stage (FIGO) | |
| IA | 81 (45%) |
| IC1 | 39 (21%) |
| IC2 | 16 (8.8%) |
| IC3 | 25 (14%) |
| IIA | 9 (4.9%) |
| IIB | 12 (6.6%) |
| Risk category | |
| Low risk (IA/IC1) | 120 (66%) |
| High risk (IC2/IC3/IIA/IIB) | 62 (34%) |
| Concordant endometriosis | |
| Absent | 60 (33%) |
| Present | 122 (67%) |
| p53 IHC | |
| Aberrant | 3 (4.5%) |
| Wild-type | 63 (95%) |
| Unknown | 116 |
| MMR IHC | |
| Retained | 76 (93%) |
| Deficient | 6 (7.3%) |
| Unknown | 100 |
FIGO, Federation of Gynecology and Obstetrics; IHC, immunohistochemistry; MMR, mismatch repair.